Back
DiaMedica Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
DMAC
DiaMedica Therapeutics, Inc.
Last Price:
$8.42
Seasonality Move:
9.66%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and DMAC is experiencing buying pressure, which is a positive indicator for future bullish movement.
DiaMedica Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.51 | Sell |
| 20-day SMA: | 8.36 | Buy |
| 50-day SMA: | 8.39 | Buy |
| 200-day SMA: | 6.29 | Buy |
| 8-day EMA: | 8.46 | Sell |
| 20-day EMA: | 8.37 | Buy |
| 50-day EMA: | 8.19 | Buy |
| 200-day EMA: | 6.81 | Buy |
DiaMedica Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 51.57 | Buy |
| Chaikin Money Flow: | 115787 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.92 - 8.64) | Buy |
| Bollinger Bands (100): | (6.82 - 8.66) | Buy |
DiaMedica Therapeutics, Inc. Technical Analysis
| Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for DiaMedica Therapeutics, Inc. Stock
Is DiaMedica Therapeutics, Inc. Stock a Buy?
-
DiaMedica Therapeutics, Inc. share price is 8.42 while DMAC 8-day simple moving average is 8.51, which is a Sell signal.
-
The stock price of DMAC is 8.42 while DiaMedica Therapeutics, Inc. 20-day SMA is 8.36, which makes it a Buy.
-
DiaMedica Therapeutics, Inc. 50-day simple moving average is 8.39 while DMAC share price is 8.42, making it a Buy technically.
-
DMAC stock price is 8.42 and DiaMedica Therapeutics, Inc. 200-day simple moving average is 6.29, creating a Buy signal.
DMAC Technical Analysis vs Fundamental Analysis
Buy
56
DiaMedica Therapeutics, Inc. (DMAC)
is a Buy
Is DiaMedica Therapeutics, Inc. a Buy or a Sell?
-
DiaMedica Therapeutics, Inc. stock is rated a BuyThe current DiaMedica Therapeutics, Inc. [DMAC] share price is $8.42. The Score for DMAC is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
DiaMedica Therapeutics, Inc. Stock Info
Market Cap:
438.5M
Price in USD:
8.42
Share Volume:
180.6K
DiaMedica Therapeutics, Inc. 52-Week Range
52-Week High:
10.42
52-Week Low:
3.19
Buy
56
DiaMedica Therapeutics, Inc. (DMAC)
is a Buy
DiaMedica Therapeutics, Inc. Share Price Forecast
-
What is the DiaMedica Therapeutics, Inc. stock price today?The DiaMedica Therapeutics, Inc. stock price is 8.42 USD today.
-
Will DMAC stock go up or go down?DiaMedica Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is DiaMedica Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, DiaMedica Therapeutics, Inc. is not overvalued.
Is DiaMedica Therapeutics, Inc. Stock a Buy?
-
DiaMedica Therapeutics, Inc. share price is 8.42 while DMAC 8-day exponential moving average is 8.46, which is a Sell signal.
-
The stock price of DMAC is 8.42 while DiaMedica Therapeutics, Inc. 20-day EMA is 8.37, which makes it a Buy.
-
DiaMedica Therapeutics, Inc. 50-day exponential moving average is 8.19 while DMAC share price is 8.42, making it a Buy technically.
-
DMAC stock price is 8.42 and DiaMedica Therapeutics, Inc. 200-day simple moving average is 6.81, creating a Buy signal.
Fundamental Analysis of DiaMedica Therapeutics, Inc.
Is DiaMedica Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.12 per share.
Technical Analysis of DiaMedica Therapeutics, Inc.
Should I short DiaMedica Therapeutics, Inc. stock?
-
DMAC Moving Average Covergence Divergence (MACD) indicator is 0.08, suggesting DiaMedica Therapeutics, Inc. is a Buy
-
DiaMedica Therapeutics, Inc. Relative Strength Index (RSI) is 51.57, which suggest DiaMedica Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for DiaMedica Therapeutics, Inc. is (7.92 - 8.64), which suggest DiaMedica Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for DiaMedica Therapeutics, Inc. is (6.82 - 8.66), which suggest DiaMedica Therapeutics, Inc. is a Buy
* DiaMedica Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.